ANI Pharmaceuticals ANIP Total debt

Total debt at other companies

Amneal Pharmaceuticals, Inc.AMRX

$2.57B+18.0%

ViatrisVTRS

$13.63B-7.7%

AnaptysBio, Inc.ANAB

$13.61K-99.9%

ALN

Alnylam PharmaceuticalsALNY

$256.43M-5.2%

Eton Pharmaceuticals, Inc.ETON

$31.26M+3.7%

Aurinia PharmaceuticalsAUPH

$80.62M-17.7%

FAQ

What is ANI Pharmaceuticals's total debt?

ANI Pharmaceuticals (ANIP) reported total debt of $301.48M in Q2 2026.

How has ANI Pharmaceuticals's total debt changed year-over-year?

ANI Pharmaceuticals's total debt decreased by 4.2% year-over-year, from $314.7M to $301.48M.

What is the long-term trend for ANI Pharmaceuticals's total debt?

Over 5 years (2020 to 2025), ANI Pharmaceuticals's total debt has grown at a 11.5% compound annual growth rate (CAGR), from $185.99M to $320.36M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.